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Abstract.  The nematode Caenorhabditis  elegans has 
two type IV collagen genes homologous to the mam- 
malian al(IV) and t~2(IV)  collagen genes. We demon- 
strate by transgenic  rescue of mutant animals that the 
genetic locus encoding the C.  elegans ot2(IV)  collagen 
gene is let-2 on the X  chromosome.  The most severe 
effect of mutations in let-2 is temperature-sensitive 
embryonic lethality.  The embryonic lethal phenotype is 
similar to that seen in animals with mutations in the 
a l(IV) collagen gene, emb-9.  The sequence of the 
entire C.  elegans a2(IV) collagen gene is presented. 
Comparisons with mammalian type IV collagen se- 
quences show high amino acid sequence conservation 
in the C-terminal  NC1  domain and of crosslinking 
residues (Cys and Lys) in the N-terminal 7S domain. 
RT-PCR analysis shows that transcripts  of the C.  ele- 
gans  t~2(IV)  collagen gene are alternatively spliced. 
Transcripts  contain one of two mutually exclusive 
exons, exon 9 or 10.  These exons encode very similar 
products, differing primarily in the sequence of a 9-10 
amino acid Gly-X-Y interruption.  The expression of 
these alternatively spliced ct2(IV) collagen transcripts 
is developmentally regulated.  In embryos over 90%  of 
the ot2(IV)  collagen mRNA contains exon 9,  while lar- 
val and adult RNAs contain 80-90%  exon  10.  This 
shift in expression of alternative a2(IV) collagen tran- 
scripts suggests that C.  elegans embryos may require a 
different form of t~2(IV)  collagen than do larvae and 
adults. 
B 
ASEMENT membranes are thin sheets of extracellular 
matrix that underlie epithelial  and endothelial  cells; 
they  also  surround  individual  muscle  cells,  nerve 
cells, and adipocytes.  Basement membranes are thought  to 
be involved in many critical biological processes, including 
cell adhesion, cell migration,  morphogenesis, tissue regen- 
eration and repair,  and macromolecular filtration  (Timpl, 
1989; Farquhar,  1991). Type IV collagen  is a major struc- 
tural component of basement membranes (Glanville,  1987). 
The type IV collagen molecule is a heterotrimer of about 500 
kD, most commonly composed of two or(iv) chains and one 
oL20V) chain.  Three additional type IV collagen chains (or3, 
or4, and or5) have recently been identified (Saus et al., 1988; 
Morrison et al., 1991; Gunwar et al., 1990; Hostikka et al., 
1990).  In  contrast  to  the ubiquitous o~l(IV) and  ot2(IV) 
chains,  these additional  chains  appear to be localized pri- 
marily,  though not exclusively,  in kidney glomerular base- 
ment membranes. In the type IV collagen molecule, three a 
chains are arranged in a collagenous  (GIy-X-Y)n triple helix 
that comprises about three-fourths of the molecule.  The Gly- 
X-Y sequence is punctuated with numerous interruptions, 
ranging  from 1 to 24 amino acids in length.  These interrup- 
tions are thought to produce sites of flexibility in the triple 
helical  domain, and they have also been proposed to act as 
binding  sites  for other  basement  membrane  components 
(Charonis and Tsilibary 1990). Each type IV ot chain has two 
noncollagenous  domains,  one at the NH2 terminus,  which 
forms part of the 7S domain, and one at the COOH-terminus, 
the NC1 domain. 
Type IV collagen molecules aggregate to form a complex 
three-dimensional  network of highly  branched  filaments, 
which is the major structural  support of the basement mem- 
brane (Yurchenco and Furthmayr,  1984). The type IV colla- 
gen network is formed by a variety of interactions,  including 
formation  of tetramers  through  7S domains,  formation  of 
dimers through  NC1  domains,  and lateral  interactions  be- 
tween molecules along the length of the triple-helical  domain 
(Yuchenco  and  Ruben,  1987).  In  addition  to  these  self- 
interactions,  type IV collagen binds cell surface receptors, 
and also binds other basement membrane components,  such 
as  laminin,  heparan  sulfate  proteoglycans,  and  nidogen 
(Charonis and Tsilibary, 1990). Any or all of these additional 
binding  activities  may be involved in basement membrane 
network formation,  but the detailed structure of this network 
is as yet unknown. 
In an effort to understand the role of type IV collagen in 
the functioning  of basement membranes,  we have  under- 
taken a genetic  and molecular characterization  of type IV 
collagen in the nematode Caenorhabditis elegans. We have 
shown that C. elegans has two type IV collagen genes,  ho- 
mologous to the al(iv) and ot2(iv) genes of mammals (Guo 
and Kramer,  1989).  The NC1  domains of the or(iv) and 
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acid sequence identity, respectively, to the NC1 domains of 
human or(IV) and ot2(IV) collagen. The two C. elegans type 
IV collagen genes are on different chromosome (Guo and 
Kramer, 1989). In contrast, in mouse and human, the otl(IV) 
and ot2(IV)  collagen genes are on the same chromosome 
about 140-bp apart, and are transcribed from a common bi- 
directional promoter (Burbelo et al.,  1988;  Kaytes et al., 
1988;  Poschl et al., 1988;  Soininen et al.,  1988).  We have 
previously identified the genetic locus for the C.  elegans 
cd(IV) collagen gene as emb-9 on chromosome III (Guo et 
al., 1991). Mutations in emb-9 cause temperature-sensitive 
lethality  during  late  embryogenesis,  demonstrating  that 
defects in basement membranes  can  disrupt  normal em- 
bryonic development. 
In this work, the genetic locus for the o~2(IV) collagen 
chain in C. elegans is identified as let-2 on the X chromo- 
some. Like the or(IV) collagen gene in C. elegans, muta- 
tions in the et2(IV)  collagen gene also have temperature- 
sensitive embryonic lethal phenotypes. The sequence of the 
entire C.  elegans et2(IV)  chain is reported and compared 
with other a2(IV) collagen chains. We also show that the C. 
elegans ot2(IV) chain undergoes alternative splicing to pro- 
duce two different transcripts whose relative levels change 
dramatically during development. 
Materials and Methods 
Transgenic Rescue of let-2 Mutant Animals 
The phage clone CH#1,  containing the entire wild-type sequence of the 
ct2(IV) collagen gene (Guo and Kramer, 1989) was injected into let-2 mu- 
tant animals as described in Mello et al. (1991). In most cases CH#1  was 
co-injected with a clone (pRF4) containing a mutant rol-6 gene (Kramer 
et al., 1990),  which acts as a dominant cotransformation marker (Mello et 
al.,  1991).  Adult let-2(g25) and let-2(g30) hermaphrodites raised at 15°C 
were injected once in each distal gonad arm. Injected animals were placed 
at 25°C, and the incidence of viable and fertile offspring produced at 25°C 
was observed. 
DNA Sequence Analysis 
Fragments of the original phage clone CH#1  (Guo and Kramer, 1989) were 
subcloned into Bluescribe. Nucleotide sequences were determined from 
both strands by the Sanger dideoxynucleotide chain-termination method 
(Sanger et al., 1977) using Sequeuase (United States Biochemical Corpora- 
tion, Cleveland, OH), using both universal and sequence-specific oligonu- 
cleotide primers. In some eases, sequences were obtained from nested dele- 
tions of larger clones made using exonuclease [] and SI nuclease (Henikoff, 
1984). 
Determination of the Start of Transcription by 
Primer Extension 
Primer extension and RNA sequencing were performed essentially as de- 
scribed by Bektesh et al. (1988).  An end-labeled 20-mer synthetic oligonu- 
cleotide primer located 237-bp downstream of the start codon ATG was an- 
nealed  to  60  tzg  C.  elegans total  RNA  and  extended  with  avian 
myeloblastosis virus reverse transcriptase in the presence of individual 
ddNTPs to determine the RNA sequence, or in the absence of ddNTPs to 
determine the termination site. 
Preparation of Total RNA from Nematodes at Different 
Developmental Stages 
C. elegans (N2, wild-type strain) was grown and maintained on nematode 
growth medium plates, streaked with Escherichia coli strain OP50, accord- 
ing to the standard techniques described by Brenner (1974).  For these de- 
velopmental studies nematodes were grown at 25°C.  Embryos at early 
stages of development were collected by treating gravid adults (~250/~1 
packed worms) with alkaline hypoehlorite solution (30%  sodium hypo- 
chlorite:  1 M  KOH:  H20  1:2:5).  This treatment dissolved adults and re- 
leased embryos into solution. Embryos were collected by centrifugation at 
2,000 g for 2 rain, washed several times in M9 buffer (Wood,  1988) and 
total RNA was immediately extracted by resuspending the embryo pellet 
in 800/~l of TRI phenol-guanidine reagent (Molecular Research Center, 
Inc.,  Cincinnati,  OH).  The  suspension was  sonicated with  a  Branson 
Sonifier 450, and the sonicate was incubated at room temperature for 5 rain 
to dissolve ribonucleoprotein complexes. 160 #l chloroform was added, the 
sonicate incubated a further 2-3 rain at room temperature, and then cen- 
trifuged at 12,000 g for 15 min at 4°C. RNA was precipitated from the upper 
aqueous layer by addition of 400/~l isopropanol and incubation at 4°C for 
30 min. The total RNA pellet was collected by centrifugation at 10,000 g 
for 10 rain at 4°C, washed once with 70% ethanol, and air dried. The RNA 
pellet was resuspended in 20/~l of diethylpyrocarbonate-treated water and 
stored at -70*C. Embryos at later stages of development were collected by 
allowing adults to lay eggs for 2 h, washing the adults off the plate with M9 
buffer, and incubating the remaining embryos for a further 4 h. These em- 
bryos were collected by alkaline hypochiorite treatment and centrifugation, 
and extracted immediately for total RNA as described above. Nematodes 
at the first larval stage (L1) were collected by allowing adults to lay eggs 
on a large (100 ram) plate overnight, washing offthe adults, and incubating 
the plate for 1 h. Larvae that hatched in this time were collected by centrifu- 
gation, and either processed for RNA extraction immediately, or put on a 
fresh plate and incubated a further 3 h or a further 7 h before RNA extrac- 
tion. Nematodes at the later larval stages (L2 through L4) and adult stage 
were collected by allowing adults to lay eggs for 2 h, washing off the adults 
with M9 buffer, and allowing the embryos to develop for a further 24 h (L2 
larvae), 33  h (L3 larvae), 43 h  (L4 larvae), or 67 h (adult) before RNA 
isolation. 
RNA from sterile adults was prepared using the C  elegans strain BA1, 
which has the temperature-sensitive mutationfer-l(hcl)  (Ward and Miwa, 
1978).  The phenotype of thisfer-1 allele is wild-type at 15 ° and 20°C, but 
sterile at 25°C, because of  defective sperm. For production of sterile adults, 
a population offer-1 adults grown at 200C was allowed to lay eggs for several 
hours at 20°C. The adults were then discarded, eggs were shifted to 25°C 
and allowed to complete larval development at 25°C until a population of 
sterile adults was obtained. Total  RNA was extracted from these sterile 
adults as described above. 
Reverse Transcriptase and Polymerase Chain 
Reactions for Determination of the Relative Levels 
of Exons 9 and I0 
Synthesis of cDNA was performed by incubating 1-2 td stage-specific  RNA 
with 50 mM Tris-HCl, pH 8.3, 75 mM KCI, 3 mM MgC12, 10 mM DTT, 
1 mM each dNTP, 20 U RNasin (Promega Biotec, Madison, WI), 200 U 
MMLV~verse transcriptase (GIBCO-BRL, Gaithersburg, MD), and 0.1 
pmole specific downstream primer (see Fig. 4) in a total volume of 20/~l 
at 37°C for 60 rain, followed by 95°C for 10 rain. For the PCR,  1-10/~1 
of this reverse transcriptase reaction was used, along with 200/~M each 
dNTE  1/zM each specific upstream and downstream primer (Fig. 4), and 
2.5 U AmpliTaq (Perkin Elmer Cetus) in PCR buffer (10 mM Tris-HCl, pH 
8.3, 50 mM KC1, 1.5 mM MgCi2, 0.01% gelatin) in a total volume of 100 
/~1. PCR samples were overlaid with mineral oil and incubated at 94°C for 
1 rain 15 s, at 59°C for 2 rain, and at 72°C for 3 min for 30 cycles in an 
automated temperature cycler. This PCR reaction was then diluted l:100 to 
be used  in  an additional  PCR  amplification to  incorporate 32p-labeled 
dATP into the PCR product. This additional amplification was performed 
by incubating 5/~l diluted PCR product with dTTP, dGTP, and dCTP (200 
ttM  each  dNTP),  10  /~Ci ot-[32p]dATP  (Amersham Corp.,  Arlington 
Heights, IL),  1 ttM each specific upstream and downstream primer, and 
2.5 U AmpliTaq in PCR buffer in a total volume of 100/zl. The samples 
were overlaid with mineral oil and three to seven PCR temperature cycles 
were performed as described above. The reamplified PCR products were 
digested without further purification with either or both of the restriction 
enzymes BglII and DdeI. The restriction digestion products were separated 
on 8% acrylarnide gels and the gels were dried under vacuum. The relative 
amounts of digestion product obtained with each restriction enzyme were 
quantified by exposing the dried gels to an imaging plate (Fuji) for 15 rain 
to 1 h and scanning the imaging plate in a FUJIX BAS 2000 Bioimaging 
Analyzer (Fuji Photo Film Co., Ltd., Tokyo, Japan). 
The Journal  of Cell Biology,  Volume 123, 1993  256 Results 
Identification of let-2 As the Genetic Locus Encoding 
the ~2(IV) Collagen Chain in C. elegans 
We have previously shown that the cd(IV) collagen chain of 
C. elegans is encoded by the emb-9 gene on chromosome III 
(Guo et al., 1991). In our search for the genetic locus of the 
ot2(IV) collagen chain of C. elegans we assumed that muta- 
tions in the cd(IV) and c~2(IV) collagen genes should have 
similar  phenotypes.  Mutant  alleles  of  emb-9  display  a 
temperature-sensitive, embryonic lethal phenotype. Lethal- 
ity occurs late in the morphogenic phase of embryogenesis, 
and is preceded by gross morphological abnormalities. The 
emb-9 locus is highly mutable, in that random screens of the 
entire  C.  elegans  genome  for  temperature-sensitive  em- 
bryonic lethal mutations produced five emb-9 alleles, while 
most other genes were represented by only one or two alleles 
(Wood et al., 1980; Miwa et al., 1980; Cassada et al., 1981). 
High mutability has been observed in other collagen genes, 
including the human type I collagen gene (Kuivaniemi et al., 
1991). 
The C. elegans a2(IV) gene has been mapped to the right 
arm of the X  chromosome (Guo and Kramer,  1989).  The 
let-2 gene maps to this region and has properties similar to 
emb-9. Embryonic lethality in let-2 mutants occurs late in the 
morphogenic phase of embryogenesis (Isnenghi et al. 1983). 
By  Nomarski  optics,  arrested  emb-9  and  let-2  mutant 
embryos  show  very  similar  morphological abnormalities 
preceding  lethality.  The  embryonic  temperature-sensitive 
periods of let-2 and emb-9 are similar, occurring relatively 
late in embryogenesis, between the lima and pretzel stages 
(Isnenghi et al., 1983; Wood et al., 1980).  Fig. 1 shows the 
similar morphological abnormalities observed in arrested 
let-2 and emb-9 mutant embryos raised at the nonpermissive 
temperature of 25°C.  Elongation is arrested at the twofold 
stage, when embryos have elongated to about two times their 
original length. Subsequently, the arrested mutant embryos 
develop extensive constrictions and herniations (Fig.  1, A 
and B). In comparison, a wild-type (N2 strain) embryo at 
the twofold stage of elongation has a  smooth appearance 
(Fig.  1 C). Like emb-9,  let-2 is a highly mutable gene, as 
random screens of the entire C. elegans genome for EMS- 
induced temperature-sensitive embryonic lethal mutations 
yielded four let-2 alleles (Wood et al., 1980; Cassada et al., 
1981). 
Encouraged by these indications that let-2 may be the gene 
for the c~2(IV) collagen chain, we performed transgenic res- 
cue experiments. When raised at the restrictive temperature 
of 25°C, 100 % of let-2 (g25) and let-2 (g30) mutants die dur- 
ing embryogenesis. In the transgenic rescue experiments, the 
gonads of worms homozygous for the g25 and g30 alleles 
were injected with a phage clone containing the entire wild- 
type coding sequence of c~2fiv) collagen, and the animals 
placed at 25°C. Viable and fertile offspring were recovered 
from injected g25 and g30 animals. Several of  these offspring 
produced transgenic lines that are continuously viable and 
fe~le at 25°C, demonstrating that the phage DNA contains 
everything needed for rescue of the temperature-sensitive le- 
thal phenotype of let-2.  These results provide convincing 
evidence that let-2 is the c~2flV) collagen gene of C. elegans. 
In addition, 17 let-2 mutations have been shown to be single 
nucleotide alterations within the coding region of the ot2(IV) 
collagen gene (Sibley, M., E Graham, and J. Kramer, manu- 
script in preparation). 
Structure of the C. elegans a2(IV) Collagen Gene 
The C. elegans a2(IV) collagen gene is *9-kb long and con- 
tains 20 exons (Fig. 2). Primer extension and direct RNA se- 
quencing experiments confirm that the transcription start site 
is 510-hp upstream of the ATG start codon (Fig. 2). The C. 
elegans ot2(IV) collagen gene is comparable in size to the C. 
elegans t~l(IV) collagen gene (Guo et al., 1991), but is much 
smaller than the human type IV collagen genes, which are 
both >100-kb long (Soininen et al.,  1989;  Cutting et al., 
1988).  The deduced translation product of the  C.  elegans 
a2(IV)  gene is  1,758 amino acids long,  somewhat longer 
than the human a2(IV) chain of 1,712 amino acids (Hostikka 
and Tryggvason, 1988). The coding region of the C. elegans 
a2(IV) gene (Fig. 2) ha-3 a characteristic type IV collagen 
structure, consisting of a large (1,487 amino acids) central 
triple helical domain having 15 interruptions in the Gly-X-Y 
repeating  sequence,  and two  smaller noncollagenous do- 
mains, one at the NH2-terminus and one at the COOH ter- 
minus (NC1).  The gene has a potential AATAAA polyade- 
nylation signal 405 bp from the end of the coding sequence. 
The two C. elegans type IV collagen genes have substan- 
tially different intron/exon structures. The ot2(IV) gene has 
20 exons, while the al(IV) gene has only 12 (Guo et al., 
1991). There is no conservation of exon size or intron/exon 
boundaries between the two  C.  elegans  type IV collagen 
genes. Despite their dissimilarity in intron/exon structure, 
the coding regions of the major domains (7S, triple helical, 
and NC1) are all nearly identical in length in the two genes. 
The two genes also have a considerable degree of amino acid 
sequence  identity (50%  overall).  The  human od(IV)  and 
a2(IV) collagen genes also have quite different gene struc- 
tures yet highly conserved amino acid sequence (Hostikka 
and Tryggvason, 1987). 
Amino Acid Sequence of C. elegans t~2(IV) Collagen 
Fig. 3 shows the complete amino acid sequence of the C. ele- 
gans  ot2(IV)  collagen.  The percentage of amino acid se- 
quence identity between C.  elegans ot2(IV) and other type 
IV chains is presented in Table I. The o~2(IV) chain of the 
parasitic  nematode  Ascaris  suum  (Pettitt  and  Kingston, 
1991) has very high amino acid sequence identity with the 
C. elegans ot2(IV) chain in all domains, including Gly-X-Y 
interruption  sequences.  On  the  other  hand,  the  human 
cd(IV) (Brazel et al., 1987) and ct2(IV) (Hostikka and Trygg- 
vason, 1988) chains have relatively low amino acid sequence 
identifies with the C.  elegans  ct2(IV)  chain, except in the 
COOH-terminal NC1 domain. 
The primary transcript of the C.  elegans t~2flV) gene is 
alternatively spliced to produce two potential polypeptides, 
one containing exon 9 and one containing exon 10. The exon 
10-containing version (residues 229 to 265) is shown in Fig. 
3. The amino acid sequence of exon 9 is shown in Fig. 4. The 
alternative splicing of the c~2(IV) transcript is described in 
detail below. 
A comparison of the C. elegans cd(iv) and c¢2(IV) chains 
is of functional interest, since these two chains are expected 
to be in the same heterotrimer (odzct2).  In the C.  elegans 
Sibley et al. Sequence and Splicing of C. elegans a2(IV) Collagen  257 Figure 1.  DIC micrographs of C.  elegans 
embryos  grown  at  25°C.  (A)  Arrested 
emb-9(g23) mutant embryo.  (B) Arrested 
let-2(b246) mutant embryo.  (C) N2 wild- 
type  embryo  at  the  twofold  stage.  Bar, 
10 #m. 
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I  ,  I  ,  I  ,  I  ,  I  ,  I  ,  I  I  I  I  I  I  I  elegans  u2(IV) collagen gene. 
Exons are indicated by boxes, 
introns  by  horizontal  lines. 
The  GIy-X-Y  repeating  triple 
helical  domain  is  unshaded, 
the  NHe-terminal  noncol- 
lagenous domain is black, and 
the COOH-terminal  NC1  do- 
main is darkly shaded.  5" and 
3'-untranslated  regions  are 
lightly  shaded.  Interruptions 
in the GIy-X-Y repeats  are shown as solid vertical bars.  The transcription  start site determined by primer extension  is indicated,  as is a 
potential polyadenylation  signal 405  bp from the end of the coding  sequence.  A  nucleotide  scale  is shown in kilobases. 
<---  Signal  peptide  ....  >  <---  Start of GIy-X-Y  do~ain 
~(QP~KALGPVLRLAILALLAV~Y~SQATCRDC~NRGCFCVGEKGSMGAPGPQGPPGTQGIRGFPGPEGLAGPKGLKGAQGPPGPVGIKGDRGAVW4PGF  I00 
PGNDGGNGRPGEPGPPGAPGWDGCNGTDGAPGIPGRPGPPG~4PGFPGPPG~4DGL~GEPAIGYAGAPGEKGDGGHPG~PGLPGP~GRDGYPGEKGDRGDTG  200 
NAGP~GPPGEAGSPGNPGIGSIGPKGDP~DIGAMGPAGPPGPIASTMSKGTIIGPKGDLGEKGE+E~GEGGQRGYPGNGGLSGQPGLPGHKGEKGL~GP  300 
AGPRGKEGRPGNAGPPGFKGDRGLDGLGGIPGLPGQKGEAGYPGRDGPKGN~GPPGPPGGGTFNDGAPGPPGLPGRPGNPGPPGTDGYPGAPGPAGPIGN  400 
TGGPGLPGYPGNEGLPGPKGDKGDGGIPGAPGV•GPSGIPGLPGPKGEPGYRGTPGQsIPGLPGKDGKPGLDGA•GRKGENGLPGVRGPPGDSLNGLPGA  500 
PGQRGAPGPNGYDGRDGVNGLPGAPGTKGDRGGTCSACAPGTKGEKGLPGYSGQPGPQGDRGLPG~4PGPVGDAGDDGLPGPAGRPGSPGPPGQDGF~GLP  600 
GQKGEPTQLTLRPGPPGYPGLKGENGFPGQPGVDGLPGPSGPvGPPGAPGYPGEKGDAGLPGLSGKPGQDGLPGLPGNKGEAG--YYGQPGQPGFPGAKGDGG  700 
LPGLPGTPGLQGMPGEP~ENQVNPAPPGQPGLPGLPGTKGEGGYPGRPGEVGQPGFPGLPGMKGD~GLPGPPGLPGHPGVPGDKGFGGVPGLPGIPGPK  800 
GDVGNPGLPGLNGQKGEPGVGVPGQPGSPGFPGLKGDAGLPGLPGTPGLEGQRGFPG~2GLKGGDGLPGL~GQPGYPGEKGDAGLPGVPGREGSPGFPGQ  900 
DGLPGV~G~LKGEDGLPGLPGVTGLKGDLGAPGQSGAPGLPGAPGYPGMKGNAGIPGVPGFKGDGGLPGLPGLNGPKGEPGVPGMPGTPG~KGNGGLPGLP  i000 
GRDGLSGVPG~VKGDRGFNGLPGEKGEAGP~GQKGDAGLPGQPGLRGPQGP~GLPGVPGFKGETGLPGYGQPGQPGEKGLPGIPGKAGRQG~2GSPGQ  1100 
DGLPGFPG~4KGESGYPGQDGLPGRDGLPGVPGQKGDLGQSGQPGL~GAPGLDGQPGVPGIRGDKGQGGLPGIPGDRGMDGYPGQKGENGYPGQPGLPGLG  1200 
GEKGFAGTPGFPGLKGSPGYPGQDGLPGIPGLKGDSGFPGQPGQEGLPGLSGEKGMGGLPGMPGQPGQSIAGPVGPPG~2GLQGKDGFPGLPGQKGESGL  1300 
•GLPGAPGLKGESGMPGFPGAKGDLGANGIPGKRGEDGLPGVPGRDGQPGIPGLKGEVGGAGLPGQPGFPGIPGLKGEGGLPGFPGAKGEAGFPGTPGVP  1400 
GYAGEKGDGGLPGLPGRDGLPGADGPVGPPGPSGPQNLVEPGEKGLPGLPGAPGLRGEKGMPGLDGPPGNDGPPGLPGQRGNDGYPC4%PGLsGEKQ4GGL  1500 
I<---  Start  of NCI domain 
~GFPGLDGQPGGPGAPGLPGAPGAAGPAYRDGFVLVKHSQTTEVPRCPEGQTKLWDGYSLLYIEGNEKSHNQDLG~AGSCLQRFSTMPFLFCDFNNVCNY  1600 
AS~NDKSYWLSTsEAIP~4~VNEREIEPYISRCAVCEAPANTIAVHSQTIQIPNCPAGWSSLWIGYSFAMHTGAGAEGGGQSLSSPGSCLEDFRATPFIE  1700 
CNGARGSCHYFANKFSFWLTTIDNDSEFKVPESQTLKSGNLRTRVSRCQVCVKSTDGRH  1759 
Figure  3.  The amino acid se- 
quence  of  the  C.  elegans 
a20V)  collagen  chain  en- 
coded  by  let-2.  Interruptions 
in GIy-X-Y  repeating sequence 
are underlined. The sequence 
encoded  by  the  alternatively 
spliced exon 10 is boxed.  The 
predicted signal peptide is in- 
dicated.  This predicted signal 
peptide  of 26  residues  would 
result in three amino acids re- 
maining at the NH2 terminus 
preceding  the  most  NH2  ter- 
minal  of  the  conserved  cys- 
teines  in the 7S domain. 
Exon 8 
GGA  CCA  CGT  GGA CCA CCT  GGA GAG 
Gly  Pro Arg  Gly  Pro  Pro  Gly GIu 
GGA ATC  GGAAGC  ATT  GGA CCAAAA 
Gly Ile  Gly  Ser  Ile  Gly  Pro  Lys 
ggc  tat  ttg  ggt  ttt  ggg  ata  tit 
ttc  aga  aat  gct  ttt  tca  ttc  tga 
Exon 9 8glll 
gta  tit  tct  aaa  tic  tag  GGA^GAT 
Gly Asp 
GGT  CCA CCG  GGA CCA  CGT  GAG  TTC 
Gly  Pro  Pro  Gly  Pro Arg  Glu 
GGA CCT  CGC  GGAAAC  CCT  GGA 
Gly  Pro Arg  Gly Asn  Pro  Gly 
att  aat  tct  tic  tit  tit  tag 
GCC  GGT  CCG CCA  GGC  CCA ATC 
Ala  Gly  Pro Pro Gly Pro  Ile 
Ddsl 
ATT  ATC  GGT  CCT^AAG  GGA GAC 
Ile  Ile  Gly  Pro  Lys  Gly Asp 
aga  ata  ctt  aga  gca  ggc  taa 
tit ttt  aca  ccc  gcc  tta  ttt 
tca  gtt  tct  aaa  aga  agc  ctt 
tgc  ctt  tca  agc  ttc  tit  tgc 
act  aga  ata  gct  gta  tta  ttt 
tag  ctc  tgc  ctt  art ctc  ttt 
aca  aaa  ttt  taa  act  tac  acg 
ctg  cat  agc  tgg  ttt  tcc  gtg 
ccc  ctc  tat  gtt  tct  aat  atg 
GAG  GGA GGT  CAA CGC  GGT  TAC 
GIu  Gly  Gly Gln Arg  Gly  Tyr 
GCT  GGA  TCC  CCA  GGAAAC  CCA  2821 
Ala  Gly  Ser  Pro Gly Asn  Pro 
GGA GAT  CCT  gtg  aga  aat  tgg  2866 
Gly Asp  Pro 
cta  gaa  art  ttg  ttt  ctc  cct  2911 
act  cca  arc  art  tta  art  art  2956 
CTA GGT  TCT  GTC  GGA  CCA CCA  3001 
Leu  Gly  Ser Val  Gly  Pro  Pro 
ACC  GGA  TCC  GGC  TCA ATT  GTC  3046 
Phe Thr Gly Set Gly Set Ile Val 
GAAAAG  GGA  GAC AAG gta ctg ttt  3091 
Glu  Lys  Gly Asp  Lys 
Exon 10 
GGA GAC ATT  GGT  GCG ATG  GGA CCG  3136 
Gly Asp  Ile  Gly Ala Met  Gly  Pro 
GCC  TCC ACC ATG  TCC AAG  GGA ACC  3181 
Ala  Set Thr Met Set Lyl  Gly Thr 
CTA GGA GAG AAG  GGA GAG AAG  gca  3226 
Leu  Gly  Glu  Lys  Gly Glu  Lys 
ctg  aac  gat  tcc  aac  cat  tta  caa  3271 
acg  cta  act  cta  aca  gtt  tic  gcc  3316 
ttt  ttc  aaa  tta  ctt  cta  ctt  tct  3361 
atg  arc  ttc  cca  gag  ttc  ata  tag  3406 
ggc  art  gga  aac  ttc  tac  tac  ttc  3451 
tca  ttt  ttt  gaa  acg  gaa  aag  aga  3496 
ttt  act  gtt  agt  acg  aat  caa  taa  3541 
tgt  gtt  ttg  cta  tac  arc  taa  ttt  3586 
Exon 11 
ttt  tgt  gttgcag  GGA  GAG  CCA GGA  3632 
Gly  Glu  Pro  Gly 
CCA GGAAAT  GGA GGA  CTC  TCA GGA  3677 
Pro  Gly Asn  Gly Gly  Leu  Set  Gly 
Table  L  Amino  Acid  Sequence  Identity  between  Type  IV 
Collagen  Chains  . 
Ascaris  c~2  human c~2  C.  elegans al  human al 
C.  elegans  a2 
7S  domain  88%  53%  50%  50% 
NC 1  domain  97 %  72 %  60 %  66 % 
GLY-X-Y  83%  <10%  21%  <10% 
interruptions 
Entire  sequence  74%  48%  50%  50% 
The amino acid sequences of the major domains of C. elegans a2(IV) collagen 
were compared with those of the C. elegans al(IV), Ascaris suum a2(IV), and 
the human al(IV) and a2(IV) chains. Alignments were performed using the 
PALIGN program (IntelliGenetics,  Mountain View,  CA).  The  number of 
identical amino acids is expressed as a percentage of the total number  of amino 
acids  compared  in  each  domain.  The  human,  C.  elegans,  and  Ascaris 
sequences were taken from the sources referenced in the text. 
Figure  4.  Exon/intron  structure  of the exon  8  to  11  region of the 
C.  elegans  a2(IV)  collagen gene.  The complete sequence  of exon 
11 is not shown. Numbering of nucleotides designates the transcrip- 
tion  start  site  as  +1.  Exon  sequences  are  capitalized;  intron se- 
quences are lower case.  Interruptions in the GIy-X-Y sequence and 
the unusual  splice  donors  of introns  9  and  10 are shown in bold 
type. Primers used in the RT-PCR are underlined. Restriction sites 
for BgllI (exon 9) and DdeI (exon  10) are indicated.  Note that for 
splicing  to  exon  11,  exon  9  must  use  the  unusual  splice  donor 
GTACT, while exon 10 must use the unusual splice donor GCAAG. 
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GIy-X-Y sequence are in the same (or very close) positions, 
and those interruptions in the same position tend to be the 
same length. In both chains, most interruptions are located 
in  the  NH2-terminal  half of the  GIy-X-Y  repeat domain: 
10/15 for the ot2(IV) chain, and 12/17 for the od0V) chain. 
Despite the conservation of interruption location and length 
in the or(IV) and ot20V) collagen chains of C. elegans,  the 
amino acid sequence identity between corresponding inter- 
ruptions is very low (Table I). 
Alternative Splicing of the C  elegans a2(IV) 
Collagen Transcript 
The  C.  elegans  ot2(IV)  gene  has  an  unusual  intron/exon 
structure in the region spanning exons 8 through 11 (Fig. 2). 
Fig. 4 shows the complete nucleotide sequence of this region 
of the gene. The putative exons 9 and  10 are separated by 
a putative intron that is only 30-bp long. This length is con- 
sidered to be too short for a functional intron in C. elegans 
(Blumenthai and  Thomas,  1988).  The 5'-splice donor se- 
quences of introns 9 and  10 are also unusual:  the intron 9 
donor has a CT in place of the consensus AG and the intron 
10 donor has a C in place of the normally invariant T in the 
second position.  Exons 9  and  10 appear to be duplicates, 
having  the  general  structure  (Gly-X-Y)5-9  or  10  amino 
acid  interruption-(Gly-X-Y)4.  The  interruption  is  nine 
amino acids long in exon 9, and 10 amino acids long in exon 
10.  This unusual intron/exon structure indicated that these 
exons could be spliced in some unconventional manner. 
To investigate the splicing of exons 9 and 10, we performed 
reverse transcriptase  (RT)t-PCR  on  RNA  prepared  from 
mixed populations of C  elegans.  The primers used were 1o- 
1. Abbreviation  used in this paper: RT, reverse  transcriptase. 
cated in exons 8 and 11, flanking the region of interest (Fig. 
4).  Fig.  5  shows  the possible RT-PCR products that could 
be obtained using these primers.  If the  spliced transcript 
contained both exons 9 and 10, an RT-PCR product 312-bp 
long would be produced. On the other hand, RT-PCR prod- 
ucts of 204 or 201 bp would be produced if either exon 9 or 
exon 10, respectively, were missing from the spliced tran- 
script (Fig. 5). The resulting RT-PCR product was slightly 
above 200-bp long, large enough to contain either exon 9 or 
exon 10, but not both exons (Fig. 6, lane 2). To determine 
which exon(s) were present in the RT-PCR product, we used 
restriction sites unique to each exon, BglII in exon 9,  and 
DdeI in exon 10. The RT-PCR product is digested to some 
extent by both enzymes (Fig. 6), indicating that both exons 
9 and 10 are present in two separate transcripts in this mixed 
population RNA.  To confirm these results, RT-PCR prod- 
ucts were cloned and selected by hybridization to oligonucle- 
otide probes specific for either exon 9 or 10. The sequence 
of the clones was as predicted in options B and C of Fig. 5, 
i.e., the clones hybridizing to the exon 9-specific probe con- 
tained  exons  8,  9,  and  11  (option  B),  while  the  clones 
hybridizing to the exon 10-specific probe contained exons 8, 
10, and 11 (option C). As a result of this alternative splicing, 
the triple helical region of the C. elegans ot2(IV) chain will 
be exactly the same size as the triple helical region of the C. 
elegans or(IV) chain (1,487 amino acids) if exon 10 is used, 
or one amino acid shorter than that of the otl(IV)  chain if 
exon 9 is used. 
Developmental Regulation of  Alternative Splicing of 
the C. elegans ~2(IV) Collagen Transcript 
The ratio of exon 9 to exon 10 in an RNA sample can be esti- 
mated by RT-PCR using the primers shown in Fig. 4. These 
primers flank exons 9 and 10, so both exons are amplified to- 
Figure 5.  Potential  RT-PCR 
products  that  could  be  ob- 
tained from the exon 8-11 re- 
gion of the C. elegans ~2(IV) 
collagen  gene.  Sizes  of the 
potential  products  in  base 
pairs  before and after diges- 
tion with BgUI and DdeI are 
indicated. Exons are shown as 
boxes,  introns  as  horizontal 
lines. 
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of exon 8-11 region RT-PCR 
products from mixed popula- 
tion C. elegans RNA. Lane 1, 
size standards (q~X174 HaelII 
digest);  lane  2,  undigested 
products;  lane  3,  digested 
with  BgllI  (digests  exon 
9-containing product); lane 4, 
digested  with  DdeI  (digests 
exon 10-containing product); 
lane 5, digested with BgllI and 
DdeI. 
gether in the same PCR. The relative amounts of exon 9 and 
exon 10 in the RT-PCR product can then be determined by 
observing the extent of its digestion by the exon 9-specific 
enzyme BgllI and the exon 10-specific enzyme DdeI. In an 
RNA sample prepared from a mixed population of animals 
of all developmental stages (Fig. 6), there are approximately 
one-half as many exon 9-containing transcripts as exon 10- 
containing transcripts. 
To  determine  if  the  proportion  of  exon  9-  to  exon 
10-containing  transcripts  changes  during  development, 
RNA was isolated from animals at different developmental 
stages and used as a template for RT-PCR. RNA was isolated 
from early-stage embryos  (0-2-h  postfertilization),  later- 
stage  embryos  (6-8  h  postferfilization),  L1  larvae  (<l-h 
posthatching, 3--4 h posthatching, and 7-8-h posthatching), 
L2, L3 and L4 larvae, and adults.  Fig. 7  shows autoradio- 
graphs of the restriction digests of RT-PCR products from 
the various developmental stages. It is evident that there is 
a large change in the exon 9/exon 10 ratio during develop- 
ment in C. elegans. Exon 9-containing transcripts appear to 
predominate  in  RNA  from embryos,  while exon  10-con- 
taining transcripts predominate in adult RNA.  RNA from 
larval stages appears to have an intermediate ratio of exon 
9- to exon 10-containing transcripts. Fig. 8 shows the per- 
centage of  the RT-PCR product present in exon 9-containing 
transcripts  at  the different developmental stages.  Relative 
levels of exon 9-containing transcripts are highest in embryo 
RNA (~90% exon 9) and lowest in adult RNA (,,o10% exon 
9). There is a steep decline in the ratio of exon 9 to exon 10 
between the late stages of embryogenesis (84 % exon 9) and 
the early part of the first larval (L1) stage (29 % exon 9). This 
decline in the ratio of exon 9  to exon  10 continues more 
gradually throughout larval development to the adult stage 
(Fig.  8). 
It is possible that adult tissues have no exon 9-containing 
transcripts, and that the 10% exon 9 detected in adult RNA 
is contributed by the embryos they contain. We investigated 
this  possibility by extracting RNA  from the temperature- 
sensitivefer-1 mutant strain, which at 25°C fails to produce 
embryos due to a sperm defect (Ward and Miwa,  1978). It 
would be expected that if embryos contribute substantially 
to the proportion of exon 9 observed in N2 adults, RNA ex- 
tracted fromfer-1  adults grown at 25°C would have an ex- 
tremely low or undetectable proportion of  exon 9-containing 
transcripts.  However, fer-1  adults  grown at 25°C  have an 
exon 9/exon 10 ratio of •19%  (Fig. 8), as great or greater 
than that observed in N2 adults. This indicates that embryo 
RNA does not contribute significantly to the proportion of 
exon 9-containing transcripts detected in N2  adults,  and, 
therefore,  exon 9-containing  transcripts  are  expressed in 
adult tissues. 
Discussion 
We have shown that the genetic locus encoding the C.  ele- 
gans ct2(IV) collagen chain is let-2 on the X chromosome. 
Mutations in let-2 and in the C. elegans otl(IV) collagen gene 
emb-9 cause similar phenotypes. Their most severe effect is 
embryonic lethality at the twofold stage of embryogenesis, 
with similar morphological abnormalities preceding lethal- 
ity. This similarity in phenotype between let-2 and emb-9 is 
consistent with the interaction of their products in type IV 
collagen molecules and  supramolecular aggregates  in  the 
basement membrane. A total of 24 mutant alleles of emb-9 
and let-2 have been isolated (Wood et al., 1980; Miwa et al., 
1980; Meneely and Herman, 1979; Meneely and Herman, 
1981;  Cassada  et  al.,  1981),  providing  a  foundation  for 
genetic analysis of basement membrane function and assem- 
bly in C.  elegans. 
With the completion of the amino acid sequence of the C. 
elegans a2(IV) chain,  the first non-mammalian otl/ct2(1V) 
collagen pair can now be examined.  At present,  the only 
other od/ot2(IV) pairs that have been completely sequenced 
are those of human and mouse (Brazel et al., 1987; Hostikka 
and Tryggvason, 1988; Muthukumaran et al., 1989; Saus et 
Figure 7. Autoradiographs of 
exon  8-11 region  RT-PCR 
products  from  C.  elegans 
RNA prepared at different de- 
velopmental  stages. Lane  1, 
undigested;  lane  2,  digested 
with  BglII  (digests  exon 
9-containing product); lane 3, 
digested  with  DdeI  (digests 
exon 10-containing product); 
lane 4, digested with BglII and 
DdeI. Developmental stage is 
indicated  above  each  panel. 
The L1 sample shown is from 
7-8 h L1 larval RNA. 
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Figure 8. Determination  of  the 
relative amount of exon 9 in 
exon  8-11 region  RT-PCR 
products  from  developmen- 
tally staged C. elegans RNA. 
RNA isolations were gener- 
ally performed twice for each 
developmental  stage,  and 
these  separately determined 
values are indicated by dots. 
WT, wild-type. 
al., 1989). In addition, complete sequences of the following 
type IV chains are known: human a5 (Zhou et al.,  1992), 
Drosophila al (Blumberg et al., 1988),  sea urchin od (Ex- 
posito et al., 1993),  and Ascaris suum or2 (Pettitt and King- 
ston,  1991).  In  both  the  C  elegans  and  mammalian 
od/ct2(IV) collagen pairs nearly all interruptions in the Gly- 
X-Y are in the same positions. In both pairs, interruptions in 
the same positions tend to be the same length, but have very 
low amino acid sequence identity. Conservation of the loca- 
tion  and length  of interruptions  between the  al(IV)  and 
ct2(IV)  chains indicates that areas  of potential flexibility 
would correspond. Presumably, differences in amino acid se- 
quence would not significantly affect flexibility of the chain, 
so there would be little pressure to conserve these sequences 
between or(IV) and t~2(IV) chains. 
The sequences of interruptions in a given ot chain, how- 
ever,  tend to be highly conserved between species in the 
same phylum. In ct2(IV) interruptions, for example, there is 
70%  amino  acid  sequence  identity between  human  and 
mouse and 83 % identity between C  elegans and Ascaris. 
This degree of sequence identity is greater than that for the 
X and Y positions of the GIy-X-Y repeat domain, suggesting 
that there are greater functional constraints on interruption 
sequences than on X-Y sequences. Certain Gly-X-Y interrup- 
tions have especially low amino acid sequence identity be- 
tween a2(IV) chains of species in the same phylum. These 
interruptions reveal regions of relatively rapid change in the 
t~2(IV) chain. For example, interruption #10 in the C  ele- 
gans chain has only 36 % sequence identity with the Ascaris 
ct2(IV) chain. This interruption corresponds in position to 
interruption #13  in the human and mouse ot2(IV)  chain, 
which is a  24-amino acid interruption having a  disulfide- 
linked loop that is thought to protrude out of the molecule 
(Brazel et ai., 1988).  Such a loop is completely absent from 
both nematode ce2(IV) chains, indicating that this may be a 
region of rapid change in t~2(IV) collagen chains. 
We have shown that the C  elegans a2(IV) collagen mRNA 
is alternatively spliced, and that embryos express predomi- 
nantly exon 9-containing transcripts while larvae and adults 
express predominantly exon 10-containing transcripts. The 
greatest shift in the ratio of exon 9- to exon 10-containing 
transcripts occurs between late embryogenesis and early in 
the  first larval  (L1) stage,  when  the  proportion  of exon 
9-containing transcripts drops from 84 to 29%. This shift 
in the exon 9/exon 10 ratio coincides with a dramatic shift 
in C. elegans development, from a phase of rapid and exten- 
sive morphological change (embryogenesis) to a phase that 
primarily entails symmetrical growth (early larval through 
adult stages). During embryogenesis in C. elegans, the em- 
bryo is transformed in only a 5 to 6 h period from a spherical 
ball of cells to an elongated cylindrical worm, with an in- 
crease in length of about fourfold. After this period of rapid 
morphogenesis, the larval and adult stages of C  elegans de- 
velopment are essentially growth stages, characterized by 
symmetrical enlargement of tissues previously established 
during embryogenesis. The morphological changes of em- 
bryogenesis may require basement membranes with different 
properties than those present in larvae or adults. In embryos, 
modifications in type IV collagen cross-linking, glycosyla- 
tion or in interactions with other basement membrane com- 
ponents may be needed to allow rapid cell movement and 
changes in cell shape. In the mouse, embryonic basement 
membranes initially lack type IV collagen and have polymer- 
ized laminin as their major structural component (Lievo et 
al.,  1980).  Thus, mammals can also have embryonic base- 
ment membranes that appear to be structurally and function- 
ally quite different from adult basement membranes. During 
the shift from embryonic to larval development in C.  ele- 
gans, a more fluid or flexible form of t~2(IV) collagen (exon 
9-containing) may be replaced by a more permanent form 
(exon 10-containing). 
It is possible that exons 9 and 10 contain different binding 
or cross-linking sites that could change basement membrane 
characteristics during development. When the EMBL pro- 
tein data base was searched using the interruptions of exons 
9 and 10, no significant homology to any known sequence 
emerged.  However,  the interruption of exon 9  contains a 
potential glycosaminoglycan  addition site Ser-Gly (Harding- 
ham and Fosang, 1992);  this site is lacking in the exon 10 
interruption.  The sequence just NH2-terminal to the Ser- 
Gly in exon 9 is Glu-Phe-Thr-Gly, which conforms to previ- 
ous observations that Ser-Gly attachment sites for glycos- 
aminoglycans are in close association with hydrophobic and 
acidic residues (Doege et al.,  1987; Noonan et al.,  1988). 
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Figure 9.  Alignment of the amino acid sequences of the alterna- 
tively spliced exons 9 and 10 ofAscaris suum and C. elegans ~2(IV) 
collagen. Sequence of the A. suum exons is from Pettitt and King- 
ston (1991). Interruptions  in the Gly-X-Y repeating sequence are 
shown in bold type. Identical amino acids are indicated by vertical 
bars. 
Exon 10 contains a lysine residue in the central portion of 
its interruption which may provide an additional glycosyla- 
tion site, or may be used in cross-linking. 
Transcripts of the Ascaris suum ot20V) collagen gene also 
appear to be alternatively spliced at exactly the same sites 
as C  elegans ot2(IV) collagen (Pettitt and Kingston,  1991; 
I. B. Kingston, personal communication). An alignment of 
the amino acid sequences of exons 9  and  10 of these two 
nematodes is shown in Fig. 9. Exon 9, the embryonic exon 
in  C  elegans,  is more highly conserved between the two 
nematodes (81% amino acid identity) than is exon 10 (65 % 
identity). The interruption sequence of exon 9, including the 
potential glycosaminoglycan attachment sequence, is 100% 
conserved between the two nematodes. In contrast, the inter- 
ruption sequence of exon 10 is only 70%  conserved. It is 
possible that the expression of the two exons is also develop- 
mentally regulated in Ascaris.  The alternative splicing of 
exons 9 and 10 is yet another common feature between these 
highly similar nematode ,2(IV) collagen chains; alternative 
splicing has not been observed in type IV collagen from any 
other organism. The fact that alternative splicing of ct2(IV) 
collagen has been maintained between these two distantly 
related nematodes suggests that it may have an important 
role in basement membrane function. 
The unusual splice donor sites seen in both exons 9 and 
10 may be involved in the regulation of alternative splicing 
of the c~2(IV) collagen transcript. It is remarkable that the 
same unusual GCAAG splice donor site seen at the 5' end of 
intron 10 is found in the human od(IV) collagen gene at the 
5' end of intron 34 (Soininen et al.,  1989). Exon 34 is near 
the COOH-terminal end of the triple helix, about 700 amino 
acids away from the alternatively spliced region in the C  ele- 
gans ot20V) chain. Although the locations of the GCAAG 
splice donors do not correspond between the human od(IV) 
and the C  elegans o~20N) chains, the occurrence of this un- 
usual splice donor in two type IV collagen genes is, if noth- 
ing more, an extraordinary coincidence. Shapiro and Sena- 
pathy (1987) report that this  sequence was  seen only five 
times  in  1,893  published  non-immunoglobulin  gene  se- 
quences.  They propose that  genes  containing  a  GCAAG 
splice donor may have a role in regulating genetic pathways 
of cell growth and differentiation. Our observations are con- 
sistent with this proposal: we find that the transcript of a col- 
lagen gene containing this splice site is alternatively spliced 
in a developmentally regulated manner. 
Our identification of let-2 as the genetic locus of  the C  ele- 
gans ct2fIV) collagen gene allows a systematic study of type 
IV collagen function in vivo. Through the efforts of several 
laboratories,  19 mutant alleles of let-2 have been isolated 
(Meneely and Herman, 1979; Meneely and Herman, 1981; 
Cassada et al., 1981). These 19 alleles display a broad range 
of phenotypes.  The let-2  alleles with  the mildest mutant 
phenotype are viable and fertile at 15  ° and 20°C, and em- 
bryonic lethal at 250C. There are several let-2 alleles having 
phenotypes of intermediate severity, including some alleles 
that are viable and fertile at 15°C and embryonic lethal at 
both 20  ° and 25°C. Some let-2 alleles are only slightly fe~ile 
at 150C, while the most severe alleles are embryonic lethal 
at 15  °, 20  °, and 25°C. The diversity of let-2 phenotypes con- 
trasts with the similar phenotypes seen in mutants of emb-9, 
the gene encoding the C. elegans od(IV) collagen chain. All 
five emb-9  alleles  are  wild-type at  15°C,  larval lethal at 
20°C, and embryonic lethal at 250C. A broader spectrum of 
phenotypes may be revealed when additional alleles of  emb-9 
are isolated. We have identified the precise mutations in the 
,20V) collagen chain in seventeen let-2 alleles (M. Sibley, 
P. Graham, and J. Kramer, manuscript in preparation), and 
are currently examining the effects of  these mutations on type 
IV collagen synthesis and assembly. Unfortunately, none of 
these mutations are within the alternatively spliced region of 
the gene. It will be necessary to generate specific mutations 
in the alternatively spliced exons to genetically analyze their 
function. 
The  sequence data  reported  here  are available  from  EMBL/GenBanld 
DDJB under accession number Z22964. 
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